ABO and Alzheimer disease: The concentration of AβO was selected based on the levels of soluble Aβ1–42 determined in pyramidal neurons derived from the AD patient’s hippocampus [~3 μM [26]] and on previous results obtained in the group in both hippocampal [24] and cortical primary neurons [6,21].